He is an inventor or co-inventor on the following patents assigned to Versanis Bio: US20240368291A1 (ActRII antibody treatments), WO2024044782A1 (ActRII antibody fixed-dose treatments) and US20240325530A1 (combination therapies)
What do our customers think about our product
S-adenosylmethionine (SAMe) SAMe is a nutritional supplement derived from the amino acid methionine and adenosine triphosphate, a nucleic acid (De Silva 2010)
Abstract Carnitine palmitoyltransferase II (CPT II) deficiency is a rare inherited disorder of mitochondrial oxidation of long-chain fatty acids (LCFA)
References Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al
Managing and treating a sulfa allergy involves avoiding sulfa-containing drugs and seeking alternatives